M. Ghosh et al., CD40 and Bcl2 expression in squamous cell carcinoma of the lung: Correlation with apoptosis, survival, and other clinicopathological factors, J PATHOLOGY, 189(3), 1999, pp. 363-367
Citations number
29
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
CD40 is a cell surface receptor which, when ligated, modulates apoptosis in
some cell types, perhaps via activation of the expression of members of th
e Bcl2 gene family. This study sought to determine whether expression of CD
40 in a series of 134 squamous cell carcinomas (SCCs) of the lung was relat
ed to apoptosis or clinical parameters, either alone or in connection with
Bcl2 expression. Sections of SCCs were stained for CD40 and Bcl2 by immunoh
istochemical techniques. An index was determined for these two markers by c
ounting stained and unstained malignant cells under high power. Sections we
re also stained by haematoxylin and eosin for determination of the apoptoti
c index by counting apoptotic bodies. About 40 per cent of SCCs expressed C
D40 in at least some of the malignant cells, with about 10 per cent essenti
ally uniformly stained. Similar proportions expressed Bcl2, with a tendency
for expression to be mutually exclusive. Apoptosis did not correlate with
CD40 expression, nor was there evidence of a co-operative or an antagonisti
c effect with Bcl2. Bcl2 expression, on the other hand, correlated signific
antly with the apoptosis score. CD40 expression showed no significant relat
ionship with survival or any other clinicopathological parameter except plo
idy. Bcl2 expression, however, correlated with longer survival. It is concl
uded that CD40 expression in SCC of the lung does not by itself relate to a
poptosis, nor is it a useful indicator of prognosis. Copyright (C) 1999 Joh
n Wiley & Sons, Ltd.